Clinical Trial Update: Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing temocillin to cefotaxime for febrile urinary tract infections assessing disturbance of intestinal microbiota.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Cefotaxime (Cefotaxime)
• Temocillin (temocillin)

Snippet

Sponsor: Håkan Hanberger | Conditions: Urinary Tract Infections | Phase 4 | Status: COMPLETED